Wayne Forrest[email protected]MRIMultiparametric MRI can help avoid renal mass biopsiesResearchers at the University of Texas Southwestern have discovered that radiologists using multiparametric MRI have an 80% chance of detecting clear cell carcinoma in the kidneys without the need for a confirming biopsy. In addition, the technique was successful among radiologists with varying levels of expertise.January 9, 2018MRIMRI links function of brain networks to IQA person's intelligence could soon be confirmed with an MRI scan to assess how well connected and functional his or her neurological networks are, according to a study published in the January issue of Neuron.January 4, 2018Nuclear MedicineUC Davis group reports progress on total-body PET/CTResearchers at the University of California, Davis (UC Davis) report continued progress on their development of a total-body PET/CT scanner designed to image patients in less than one minute, in an article in the January issue of the Journal of Nuclear Medicine.January 4, 2018MRINEJM: No long-term effects on cardiac devices with MRIThere's good news for patients with cardiac devices who are about to undergo an MRI scan. Researchers found no long-term clinically significant adverse events with the devices in a study of more than 1,000 scans, according to results published in the December 28 issue of the New England Journal of Medicine.January 1, 2018Nuclear MedicineDeep learning analyzes PET for signs of dementiaA deep-learning algorithm that analyzed FDG-PET was able to differentiate between normal cognition and dementia. Such models could someday help radiologists diagnose Alzheimer's disease, especially if they don't see the condition often, according to a study presented at the RSNA 2017 meeting.December 21, 2017MRIFDA issues directive on GBCA labeling, safety researchThe U.S. Food and Drug Administration (FDA) on Tuesday issued a directive requiring that manufacturers of gadolinium-based contrast agents (GBCAs) add a new warning to their product labeling that notifies healthcare providers that patients could retain gadolinium long after an MRI scan.December 18, 2017MRIX-ray fluorescence detects retained gadolinium in boneAs the safety of gadolinium MRI contrast is hotly debated, one of the challenges has been detecting gadolinium deposition in living patients. Canadian researchers may have found a solution to the dilemma with an x-ray fluorescence system that can noninvasively detect trace elements of gadolinium in exposed individuals.December 18, 2017Nuclear MedicineFlorbetapir shows promise in preclinical Alzheimer's studyA preclinical study from Belgium has shown promising results with the PET tracer florbetapir for targeting amyloid plaque and tau tangles in the brain and potentially evaluating the efficacy of certain Alzheimer's treatments. Findings were published in the December issue of the Journal of Nuclear Medicine.December 17, 2017MRIMRI confirms prostate cancer with lower dose of GBCAMRI scans with a reduced dose of a gadolinium-based contrast agent (GBCA) can be more effective than scans with a standard dose in differentiating between malignant and benign lesions in prostate cancer patients, according to a study presented recently at RSNA 2017.December 13, 2017Nuclear MedicinefMRI, PET could help foresee epileptic seizure issuesResearchers have developed a method to integrate functional MR (fMRI) and PET images to identify epilepsy patients who are at high risk of continued seizures before the patients undergo potentially unsuccessful surgery, according to a study published online December 5 in Frontiers in Neuroscience.December 11, 2017Previous PagePage 56 of 239Next PageTop StoriesDigital X-Ray3D DEXA reveals lower bone density in diabetes patients3D DEXA revealed differences that conventional bone mineral density measurements did not detect.MRIGadolinium in ... beer?UltrasoundMWA safe, effective in treating hyperthyroidism with nodulesAIAI model shows promise for diagnosing prostate cancerCT'Habitat' AI model helps stratify lung nodule disease risk on LDCT